Centro Médico Teknon
Centro Médico Teknon
Spain, Barcelona
Agusti Barnadas Molins
41 years of experience
Clinic is certified :
Ovarian cancer treatment cost in Spain typically ranges from $20,000 to $35,000 for primary surgical intervention. Necessary diagnostics like a PET/CT scan run from $1,300 to $1,800, while specialized chemotherapy for ovarian cancer costs between $1,200 and $5,800. Total expenses depend on the disease stage and required cycles, offering 40-60% savings compared to the US. Leading medical hubs include Barcelona, Madrid, and Pamplona.
Typical Ovarian Cancer Treatment Costs in Spain
Bookimed Expert Insight: Advanced stage patients benefit from the high-tech infrastructure at JCI-accredited centers like Centro Médico Teknon. For those requiring complex surgical intervention, Teknon performs over 23,500 operations annually using robotic technologies. Patients seeking clinical trials should consider Quironsalud Madrid, a member of the GCIG Spanish sub-group. This provides access to novel protocols often unavailable in standard private clinics.
| Turkey | Austria | Spain | |
| Оophorectomy | from $2,943 | from $15,000 | from $9,500 |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Ovarian cancer surgery | from $9,243 | from $25,000 | from $20,000 |
| Omentectomy | from $4,500 | from $15,000 | from $12,000 |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from $22,500 | from $40,000 | from $25,000 |
Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.
He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.
Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.
She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.
She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.
Dr. Joseba Rebollo Liceaga brings over 36 years of experience of oncology experience, specializing in advanced ovarian cancer treatments at Quironsalud Torrevieja.
Principal Investigator in multiple clinical trials for ovarian, cervical, and endometrial cancer – Dr. Oaknin brings advanced research directly to patient care.